DUBLIN, Nov 11, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Drug Eluting Stents Market Analysis & Trends - Product and Drugs Used - Forecast to 2025" report to their offering.
The Global Drug Eluting Stents Market is forecast to grow at a CAGR of around 3.8% to reach approximately $9.45 billion by 2025.
This industry report analyzes the global markets for Drug Eluting Stents across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
Companies Mentioned:
- Abbott Vascular Inc
- AlviMedica Medical Technologies Inc
- Amaranth Medical, Inc.
- Arterius Ltd
- BioSurfaces, Inc
- Bioabsorbable Therapeutics, Inc.
- Biosensors International Group, Ltd
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- CARDIONOVUM GmbH
- Cordis Corporation
- Elixir Medical Corporation
- Envision Scientific Pvt. Ltd
- Genesis Technologies, LLC
- HangZhou HuaAn Biotechnology Co.,Ltd
- Johnson & Johnson
- Kyoto Medical Planning Co., Ltd.
- Medtronic Inc
- Meril Life Sciences
- Relisys Medical Devices Limited
- Sino Medical-Device Technology Co., Ltd
- Stentys, SA
- Terumo Corporation
- XTENT, Inc.
Report Structure:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Drug Eluting Stents Market, By Product
5 Drug Eluting Stents Market, By Application
6 Drug Eluting Stents Market, By Drugs Used
7 Drug Eluting Stents Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/njfpj7/drug_eluting
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
